Immunai Inc., an artificial intelligence biotechnology company, announced on Thursday a multi-year collaboration in ...

By exploiting the genetic variation in cancer cells, an already approved cancer drug demonstrated enhanced effects against ...

Anish Suri, Ph.D., president & chief scientific officer (CSO) of Cue Biopharma, to transition to principal research and immunology advisor BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.

AbbVie stock drops after emraclidine fails Phase 2 trials for schizophrenia, raising questions about its neuroscience ...

AbbVie continues to recover from one of the biggest patent cliffs in the pharmaceutical industry's history. Last year, its ...

Studies suggest that garlic may help prevent and reduce the length of your cold. The evidence is limited, but here’s what to ...

New drugs and therapies have become indispensable for treating an array of cancers. Unfortunately, they can also cause damage to the heart, a side effect that has led to the development of a new ...

Most cancer treatments—from chemotherapies to engineered immune cells—have a host of side effects, in large part because they ...

Nipocalimab was well-tolerated over the six-month study period, with no major safety signals observed. The most common adverse events (AEs) were infections and infestations: 60.4% (n=32) in the ...

Lilly develops these digital health technologies for global clinical development teams across its focus therapeutic areas of ...

Discover groundbreaking research from Emory University that has revealed that autoantibodies found in the nasal cavity may ...

Agentic AI has the potential to reshape not just healthcare, but the very foundations of biological research. By allowing ...